Skip to main content

Table 2 Possible outcome measures for use in tracking episodes of AKI

From: Establishing a continuum of acute kidney injury – tracing AKI using data source linkage and long-term follow-up: Workgroup Statements from the 15th ADQI Consensus Conference

 

Entity resolution

Initial encounter

Subsequent encounters

Kidney Health

Overall health

Kidney Health

Overall health

Population

Name

Unique identifier

Gender

Date of birth

AKI detection results/tag.

Serum creatinine measurements (baseline, during AKI and recovery).

ICD codes

Comorbidities

Complications

Resource utilization e.g. length of stay, critical care admission.

All subsequent AKI episodes, stages and timing.

eGFR.

Albuminuria.

CKD stage.

Need for RRT.

Re-hospitalization.

New diagnoses, ICD codes: CV events, cancer, infection, fracture, MAKE, MARCE.

Time and cause of death.

Patient

Name

Unique identifier

Sex

Date of birth

AKI detection results/tag

AKI stage, duration and setting

AKI etiology

Need for acute RRT

Nephrology consult

Setting of AKI, exposures and co-existing illness.

Blood pressure.

Procedures.

eGFR.

Albuminuria.

CKD stage.

Need for RRT.

Blood pressure.

Comorbidities.

Complications.

Quality of life/dependency.

Management

Name

Unique identifier

Gender

Date of birth

Treatment given for AKI.

AKI follow up plans.

Medications.

Discharge quality indicators.

Education (including patient).

Medications (including those stopped/temporarily suspended).

Frailty measures. Patient reported outcomes and symptoms.

CKD care.

Secondary prevention of AKI episodes.

Medications.

Functional recovery.

Cardiovascular risk.

Frailty measures.

Patient reported outcomes and symptoms.

Research

 

Biomarkers.

Specific therapies.

Improved methods of capturing patient reported data.

Therapies to facilitate recovery.

Use of biomarkers to predict risk/recovery.

Therapies to improve systemic outcomes.

  1. AKI acute kidney injury, ICD International Classification of Diseases, eGFR estimated glomerular filtration rate, CKD chronic kidney disease, RRT renal replacement therapy, MAKE major adverse kidney events, MARCE major adverse renal and cardiovascular events